Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AB07015

Abstract

Realization of a part of A Prospective, Multicenter, Randomised, Double-blind, Placebo-controlled, 2-parallel Groups, Phase 3 Study to Compare the Efficacy and the Safety of Masitinib at 6 mg/kg/Day Versus Placebo in the Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Keywords

• masitinib
• asthma
• corticosteroids